Tissues, Cells and Biomarkers in ARDS

Authors

Seyed Mohammad Reza Hashemian1,*, Makan Sadr2, Ali DabbaghAli Dabbagh ORCID3
1Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
2Clinical Tuberculosis and EpidemiologyResearch Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3Anesthesiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
*Corresponding Author: Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Email: [email protected]

Journal of Cellular & Molecular Anesthesia:Vol. 1, issue 1; e150238
Published online:Dec 22, 2015
Article type:Letter to the Editor
How to Cite:Hashemian SMR, Sadr M, Dabbagh A. Tissues, Cells and Biomarkers in ARDS. J Cell Mol Anesth. 2016;1(1):e150238. doi: https://doi.org/10.22037/jcma.v1i1.10576

Abstract

?The utility of biomarkers for the action of endothelium and epithelium of the pulmonary microvasculars is unknown and their action of being barrier for edema and dysfunction of them cause ARDS and its mortality rate with no specific drugs efficiency is high (1). Recently, there are many important information about biomarkers in ARDS (2). These biomarkers in ARDS can effect either cellular activation or cell injury. Currently, biomarkers are the most important research tool. The biomarkers have an important role in ARDS treatment in the function. There is an executive phase with some damage like edema and necroses. Then, fibro-proliferative phase will be happen. To understand the mechanism of repair, we focus on the function of alveolar type I (3). ?

References

  • 1.
    References are in the PDF file of the article.

Copyright

© 2016, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

17
Oct
2020

Toll-Like Receptor 4 in Acute Respiratory Distress Syndrome: Good Time to Target?

Bahador Bagheri,
Sara Salarian

Bagheri B, Salarian S. Toll-Like Receptor 4 in Acute Respiratory Distress Syndrome: Good Time to Target?. J Cell Mol Anesth. 2020;5(4):e149659. doi: https://doi.org/10.22037/jcma.v5i4.32430

30
Nov
2019

Acute Respiratory Distress Syndrome in a Patient With Suspected Influenza: A Case Report

Mahyar Sedighi,
Shokrollah Hosseinzadeh,
Abbas Allami

Sedighi M, Hosseinzadeh S, Allami A. Acute Respiratory Distress Syndrome in a Patient With Suspected Influenza: A Case Report. J Inflamm Dis. 2024;23(4):e156176. doi:

26
Aug
2016

Real-time RT-PCR Detection of HCN4 and ADAM8 genes in ventilator-associated pneumonia patients Hospitalized in intensive care unit

Hamidreza Jamaati,
Naghmeh Bahrami,
Masoum Abniki,
Payam Tabarsi,
Behrooz Farzanegan,
Atosa Doroudinia
,et al.

Jamaati H, Bahrami N, Abniki M, Tabarsi P, Farzanegan B, et al. Real-time RT-PCR Detection of HCN4 and ADAM8 genes in ventilator-associated pneumonia patients Hospitalized in intensive care unit. J Cell Mol Anesth. 2016;1(4):e149519. doi: https://doi.org/10.22037/jcma.v1i4.13372

1
Nov
2013

Brain Natriuretic Peptide: A Predictor for Severity Respiratory Distress Syndrome in Newborns

Iraj Shahramian,
Noor Mohammad Noori,
Elham Sharafi,
Abbas Ali Ramezani,
Mehran Hesaraki

Shahramian I, Noori NM, Sharafi E, Ramezani AA, Hesaraki M. Brain Natriuretic Peptide: A Predictor for Severity Respiratory Distress Syndrome in Newborns. J Compr Ped. 2013;4(4):189-93. doi: https://doi.org/10.17795/compreped-11262

9
Oct
2024
Investigation of Biochemical and Inflammatory Markers in COVID-19 Patients Hospitalized in the Intensive Care Unit: An Observational Study in Northern Iran

Investigation of Biochemical and Inflammatory Markers in COVID-19 Patients Hospitalized in the Intensive Care Unit: An Observational Study in Northern Iran

Behnaz Khodabakhshi,
Motahareh Mehghani,
Narges Lashkarbolouk,
Roghieh Golsha,
Sima Besharat,
Mahdi Mazandarani

Khodabakhshi B, Mehghani M, Lashkarbolouk N, Golsha R, Besharat S, et al. Investigation of Biochemical and Inflammatory Markers in COVID-19 Patients Hospitalized in the Intensive Care Unit: An Observational Study in Northern Iran. Compr Health Biomed Stud. 2024;2(3):e149303. doi: https://doi.org/10.5812/chbs-149303

More by these authors

Seyed Mohammad Reza HashemianPubMedScholar
Makan SadrPubMedScholar
Ali DabbaghPubMedScholar
Share
Cited by
Metrics